nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—Carmustine—malignant glioma	0.552	1	CbGbCtD
Desloratadine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00967	0.0388	CcSEcCtD
Desloratadine—Otitis media—Temozolomide—malignant glioma	0.00935	0.0376	CcSEcCtD
Desloratadine—Viral infection—Temozolomide—malignant glioma	0.00806	0.0324	CcSEcCtD
Desloratadine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00769	0.0309	CcSEcCtD
Desloratadine—Affect lability—Temozolomide—malignant glioma	0.0052	0.0209	CcSEcCtD
Desloratadine—Mood swings—Temozolomide—malignant glioma	0.005	0.0201	CcSEcCtD
Desloratadine—Breast disorder—Temozolomide—malignant glioma	0.00477	0.0192	CcSEcCtD
Desloratadine—Bronchitis—Temozolomide—malignant glioma	0.00439	0.0176	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00424	0.0171	CcSEcCtD
Desloratadine—Urinary tract infection—Carmustine—malignant glioma	0.0041	0.0165	CcSEcCtD
Desloratadine—Infestation—Temozolomide—malignant glioma	0.00407	0.0164	CcSEcCtD
Desloratadine—Infestation NOS—Temozolomide—malignant glioma	0.00407	0.0164	CcSEcCtD
Desloratadine—Urinary tract infection—Temozolomide—malignant glioma	0.00396	0.0159	CcSEcCtD
Desloratadine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00385	0.0155	CcSEcCtD
Desloratadine—Hallucination—Carmustine—malignant glioma	0.00376	0.0151	CcSEcCtD
Desloratadine—Connective tissue disorder—Carmustine—malignant glioma	0.00372	0.0149	CcSEcCtD
Desloratadine—Hepatitis—Temozolomide—malignant glioma	0.00365	0.0147	CcSEcCtD
Desloratadine—Hallucination—Temozolomide—malignant glioma	0.00364	0.0146	CcSEcCtD
Desloratadine—Pharyngitis—Temozolomide—malignant glioma	0.00363	0.0146	CcSEcCtD
Desloratadine—Connective tissue disorder—Temozolomide—malignant glioma	0.00359	0.0144	CcSEcCtD
Desloratadine—Cardiac disorder—Temozolomide—malignant glioma	0.00339	0.0136	CcSEcCtD
Desloratadine—Mental disorder—Carmustine—malignant glioma	0.00331	0.0133	CcSEcCtD
Desloratadine—Erythema—Carmustine—malignant glioma	0.00329	0.0132	CcSEcCtD
Desloratadine—Mental disorder—Temozolomide—malignant glioma	0.0032	0.0129	CcSEcCtD
Desloratadine—Erythema—Temozolomide—malignant glioma	0.00318	0.0128	CcSEcCtD
Desloratadine—Agitation—Carmustine—malignant glioma	0.00303	0.0122	CcSEcCtD
Desloratadine—Agitation—Temozolomide—malignant glioma	0.00292	0.0117	CcSEcCtD
Desloratadine—Angioedema—Temozolomide—malignant glioma	0.00291	0.0117	CcSEcCtD
Desloratadine—Convulsion—Carmustine—malignant glioma	0.00285	0.0115	CcSEcCtD
Desloratadine—Palpitations—Temozolomide—malignant glioma	0.00281	0.0113	CcSEcCtD
Desloratadine—Myalgia—Carmustine—malignant glioma	0.0028	0.0113	CcSEcCtD
Desloratadine—Cough—Temozolomide—malignant glioma	0.00278	0.0112	CcSEcCtD
Desloratadine—Convulsion—Temozolomide—malignant glioma	0.00276	0.0111	CcSEcCtD
Desloratadine—Myalgia—Temozolomide—malignant glioma	0.00271	0.0109	CcSEcCtD
Desloratadine—Oedema—Carmustine—malignant glioma	0.00269	0.0108	CcSEcCtD
Desloratadine—Infection—Carmustine—malignant glioma	0.00267	0.0107	CcSEcCtD
Desloratadine—Dry mouth—Temozolomide—malignant glioma	0.00265	0.0106	CcSEcCtD
Desloratadine—Tachycardia—Carmustine—malignant glioma	0.00262	0.0105	CcSEcCtD
Desloratadine—Oedema—Temozolomide—malignant glioma	0.0026	0.0104	CcSEcCtD
Desloratadine—Anaphylactic shock—Temozolomide—malignant glioma	0.0026	0.0104	CcSEcCtD
Desloratadine—Infection—Temozolomide—malignant glioma	0.00258	0.0104	CcSEcCtD
Desloratadine—Anorexia—Carmustine—malignant glioma	0.00256	0.0103	CcSEcCtD
Desloratadine—Nervous system disorder—Temozolomide—malignant glioma	0.00255	0.0102	CcSEcCtD
Desloratadine—Anorexia—Temozolomide—malignant glioma	0.00248	0.00995	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00245	0.00984	CcSEcCtD
Desloratadine—Insomnia—Carmustine—malignant glioma	0.00243	0.00977	CcSEcCtD
Desloratadine—Dyspnoea—Carmustine—malignant glioma	0.0024	0.00963	CcSEcCtD
Desloratadine—Somnolence—Carmustine—malignant glioma	0.00239	0.0096	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00237	0.00951	CcSEcCtD
Desloratadine—Insomnia—Temozolomide—malignant glioma	0.00235	0.00944	CcSEcCtD
Desloratadine—Decreased appetite—Carmustine—malignant glioma	0.00234	0.00939	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00232	0.00932	CcSEcCtD
Desloratadine—Dyspnoea—Temozolomide—malignant glioma	0.00231	0.0093	CcSEcCtD
Desloratadine—Somnolence—Temozolomide—malignant glioma	0.00231	0.00928	CcSEcCtD
Desloratadine—Dyspepsia—Temozolomide—malignant glioma	0.00229	0.00919	CcSEcCtD
Desloratadine—Decreased appetite—Temozolomide—malignant glioma	0.00226	0.00907	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00224	0.00901	CcSEcCtD
Desloratadine—Fatigue—Temozolomide—malignant glioma	0.00224	0.009	CcSEcCtD
Desloratadine—Gastrointestinal pain—Carmustine—malignant glioma	0.0022	0.00883	CcSEcCtD
Desloratadine—Body temperature increased—Carmustine—malignant glioma	0.00212	0.00854	CcSEcCtD
Desloratadine—Abdominal pain—Carmustine—malignant glioma	0.00212	0.00854	CcSEcCtD
Desloratadine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00212	0.00853	CcSEcCtD
Desloratadine—Urticaria—Temozolomide—malignant glioma	0.00206	0.00829	CcSEcCtD
Desloratadine—Abdominal pain—Temozolomide—malignant glioma	0.00205	0.00825	CcSEcCtD
Desloratadine—Body temperature increased—Temozolomide—malignant glioma	0.00205	0.00825	CcSEcCtD
Desloratadine—Hypersensitivity—Carmustine—malignant glioma	0.00198	0.00796	CcSEcCtD
Desloratadine—Asthenia—Carmustine—malignant glioma	0.00193	0.00775	CcSEcCtD
Desloratadine—Hypersensitivity—Temozolomide—malignant glioma	0.00191	0.00769	CcSEcCtD
Desloratadine—Asthenia—Temozolomide—malignant glioma	0.00186	0.00749	CcSEcCtD
Desloratadine—Diarrhoea—Carmustine—malignant glioma	0.00184	0.00739	CcSEcCtD
Desloratadine—Pruritus—Temozolomide—malignant glioma	0.00184	0.00738	CcSEcCtD
Desloratadine—Dizziness—Carmustine—malignant glioma	0.00178	0.00714	CcSEcCtD
Desloratadine—Diarrhoea—Temozolomide—malignant glioma	0.00178	0.00714	CcSEcCtD
Desloratadine—Dizziness—Temozolomide—malignant glioma	0.00172	0.0069	CcSEcCtD
Desloratadine—Vomiting—Carmustine—malignant glioma	0.00171	0.00687	CcSEcCtD
Desloratadine—Rash—Carmustine—malignant glioma	0.00169	0.00681	CcSEcCtD
Desloratadine—Dermatitis—Carmustine—malignant glioma	0.00169	0.0068	CcSEcCtD
Desloratadine—Headache—Carmustine—malignant glioma	0.00168	0.00676	CcSEcCtD
Desloratadine—Vomiting—Temozolomide—malignant glioma	0.00165	0.00663	CcSEcCtD
Desloratadine—Rash—Temozolomide—malignant glioma	0.00164	0.00658	CcSEcCtD
Desloratadine—Dermatitis—Temozolomide—malignant glioma	0.00164	0.00657	CcSEcCtD
Desloratadine—Headache—Temozolomide—malignant glioma	0.00163	0.00654	CcSEcCtD
Desloratadine—Nausea—Carmustine—malignant glioma	0.0016	0.00641	CcSEcCtD
Desloratadine—Nausea—Temozolomide—malignant glioma	0.00154	0.0062	CcSEcCtD
Desloratadine—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000121	0.000608	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.00012	0.000599	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.000119	0.000598	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ASMT—malignant glioma	0.000119	0.000598	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—BCAN—malignant glioma	0.000119	0.000597	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—COX8A—malignant glioma	0.000119	0.000596	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000118	0.000593	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000118	0.000591	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000116	0.000582	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000116	0.000579	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SUFU—malignant glioma	0.000113	0.000568	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000113	0.000568	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000112	0.000562	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HEY2—malignant glioma	0.000112	0.000561	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000111	0.000557	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000111	0.000554	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GFAP—malignant glioma	0.000109	0.000548	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KNG1—malignant glioma	0.000109	0.000544	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000108	0.000543	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000106	0.000534	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000106	0.000532	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000106	0.000531	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000104	0.00052	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000104	0.00052	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ASMT—malignant glioma	0.000101	0.000506	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.000101	0.000505	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.87e-05	0.000495	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—IDH2—malignant glioma	9.83e-05	0.000493	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	9.63e-05	0.000483	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MMP3—malignant glioma	9.62e-05	0.000482	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	9.62e-05	0.000482	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—IDH2—malignant glioma	9.59e-05	0.000481	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BCAN—malignant glioma	9.5e-05	0.000476	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.26e-05	0.000465	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2B6—malignant glioma	9.24e-05	0.000463	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAG2—malignant glioma	9.2e-05	0.000461	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—IDH2—malignant glioma	9.04e-05	0.000453	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2B6—malignant glioma	9.02e-05	0.000452	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—IDH2—malignant glioma	8.96e-05	0.000449	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	8.85e-05	0.000444	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	8.65e-05	0.000434	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2B6—malignant glioma	8.5e-05	0.000426	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—IDH1—malignant glioma	8.45e-05	0.000424	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.45e-05	0.000424	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2B6—malignant glioma	8.42e-05	0.000422	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—IDH1—malignant glioma	8.25e-05	0.000413	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	8.24e-05	0.000413	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	8.18e-05	0.00041	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SPHK1—malignant glioma	8.18e-05	0.00041	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2C18—malignant glioma	8.01e-05	0.000402	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SPHK1—malignant glioma	7.98e-05	0.0004	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2C18—malignant glioma	7.82e-05	0.000392	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—H3F3A—malignant glioma	7.78e-05	0.00039	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—IDH1—malignant glioma	7.77e-05	0.00039	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—F2—malignant glioma	7.73e-05	0.000387	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCR3—malignant glioma	7.71e-05	0.000386	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—IDH1—malignant glioma	7.7e-05	0.000386	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—IDH2—malignant glioma	7.66e-05	0.000384	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.55e-05	0.000379	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SPHK1—malignant glioma	7.52e-05	0.000377	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	7.51e-05	0.000377	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—YWHAE—malignant glioma	7.5e-05	0.000376	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NTRK2—malignant glioma	7.5e-05	0.000376	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FLT1—malignant glioma	7.46e-05	0.000374	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SPHK1—malignant glioma	7.45e-05	0.000374	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DUSP6—malignant glioma	7.43e-05	0.000373	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	7.39e-05	0.000371	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2C18—malignant glioma	7.37e-05	0.000369	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAG1—malignant glioma	7.34e-05	0.000368	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	7.3e-05	0.000366	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.3e-05	0.000366	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.27e-05	0.000364	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.22e-05	0.000362	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2B6—malignant glioma	7.2e-05	0.000361	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FBXW7—malignant glioma	7.19e-05	0.00036	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	7.05e-05	0.000353	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—F2—malignant glioma	7.02e-05	0.000352	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.89e-05	0.000345	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.88e-05	0.000345	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	6.76e-05	0.000339	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	6.71e-05	0.000337	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.64e-05	0.000333	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	6.6e-05	0.000331	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—IDH1—malignant glioma	6.58e-05	0.00033	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	6.55e-05	0.000329	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	6.5e-05	0.000326	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTT1—malignant glioma	6.48e-05	0.000325	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KNG1—malignant glioma	6.41e-05	0.000321	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SPHK1—malignant glioma	6.37e-05	0.000319	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—malignant glioma	6.32e-05	0.000317	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.27e-05	0.000315	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.24e-05	0.000313	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT2—malignant glioma	6.14e-05	0.000308	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.14e-05	0.000308	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NTRK1—malignant glioma	6.11e-05	0.000306	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS1—malignant glioma	6.07e-05	0.000304	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.05e-05	0.000304	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.05e-05	0.000303	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—malignant glioma	5.96e-05	0.000299	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS1—malignant glioma	5.92e-05	0.000297	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—malignant glioma	5.91e-05	0.000296	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	5.9e-05	0.000296	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.88e-05	0.000295	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP3—malignant glioma	5.68e-05	0.000285	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	5.66e-05	0.000284	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—BCHE—malignant glioma	5.64e-05	0.000283	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	5.63e-05	0.000282	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS1—malignant glioma	5.58e-05	0.00028	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC5A5—malignant glioma	5.57e-05	0.000279	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS1—malignant glioma	5.53e-05	0.000278	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.51e-05	0.000276	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—BCHE—malignant glioma	5.51e-05	0.000276	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTK2—malignant glioma	5.47e-05	0.000274	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	5.44e-05	0.000273	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC5A5—malignant glioma	5.44e-05	0.000273	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HES1—malignant glioma	5.37e-05	0.000269	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.36e-05	0.000269	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NCOR1—malignant glioma	5.34e-05	0.000268	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.27e-05	0.000264	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RAF1—malignant glioma	5.27e-05	0.000264	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.22e-05	0.000262	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—malignant glioma	5.2e-05	0.000261	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BCHE—malignant glioma	5.19e-05	0.00026	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.17e-05	0.000259	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BCHE—malignant glioma	5.15e-05	0.000258	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	5.14e-05	0.000258	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.13e-05	0.000257	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	5.11e-05	0.000256	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.08e-05	0.000255	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—malignant glioma	5.05e-05	0.000253	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.01e-05	0.000251	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—malignant glioma	4.97e-05	0.000249	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	4.94e-05	0.000248	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.81e-05	0.000241	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.76e-05	0.000239	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS1—malignant glioma	4.73e-05	0.000237	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—malignant glioma	4.72e-05	0.000237	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.71e-05	0.000236	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—malignant glioma	4.71e-05	0.000236	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFB—malignant glioma	4.59e-05	0.00023	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR1—malignant glioma	4.57e-05	0.000229	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.56e-05	0.000228	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—malignant glioma	4.5e-05	0.000226	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—malignant glioma	4.49e-05	0.000225	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BCHE—malignant glioma	4.4e-05	0.00022	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—malignant glioma	4.38e-05	0.00022	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAT—malignant glioma	4.37e-05	0.000219	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CAV1—malignant glioma	4.35e-05	0.000218	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.34e-05	0.000218	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—malignant glioma	4.31e-05	0.000216	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAT—malignant glioma	4.26e-05	0.000214	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.15e-05	0.000208	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FN1—malignant glioma	4.14e-05	0.000208	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—F2—malignant glioma	4.14e-05	0.000208	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—malignant glioma	4.13e-05	0.000207	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOR1—malignant glioma	4.13e-05	0.000207	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.11e-05	0.000206	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BAD—malignant glioma	4.1e-05	0.000205	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—malignant glioma	4.09e-05	0.000205	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.07e-05	0.000204	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	4.06e-05	0.000203	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOR1—malignant glioma	4.03e-05	0.000202	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAT—malignant glioma	4.02e-05	0.000201	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAT—malignant glioma	3.98e-05	0.0002	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD80—malignant glioma	3.97e-05	0.000199	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	3.97e-05	0.000199	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—malignant glioma	3.97e-05	0.000199	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGF—malignant glioma	3.92e-05	0.000197	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTPN11—malignant glioma	3.9e-05	0.000195	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOR1—malignant glioma	3.79e-05	0.00019	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOR1—malignant glioma	3.76e-05	0.000189	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—malignant glioma	3.73e-05	0.000187	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT2—malignant glioma	3.63e-05	0.000182	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—malignant glioma	3.61e-05	0.000181	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.55e-05	0.000178	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—malignant glioma	3.5e-05	0.000175	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	3.49e-05	0.000175	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	3.45e-05	0.000173	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—malignant glioma	3.41e-05	0.000171	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAT—malignant glioma	3.4e-05	0.000171	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAV1—malignant glioma	3.36e-05	0.000169	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF2—malignant glioma	3.34e-05	0.000167	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAV1—malignant glioma	3.28e-05	0.000165	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOR1—malignant glioma	3.21e-05	0.000161	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.21e-05	0.000161	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	3.14e-05	0.000157	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—malignant glioma	3.12e-05	0.000157	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAF1—malignant glioma	3.11e-05	0.000156	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAV1—malignant glioma	3.09e-05	0.000155	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—malignant glioma	3.08e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAV1—malignant glioma	3.07e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.06e-05	0.000154	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	3.04e-05	0.000152	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—malignant glioma	2.99e-05	0.00015	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—malignant glioma	2.96e-05	0.000148	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.93e-05	0.000147	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.92e-05	0.000146	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—malignant glioma	2.89e-05	0.000145	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.82e-05	0.000141	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.82e-05	0.000141	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.8e-05	0.00014	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.79e-05	0.00014	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—malignant glioma	2.79e-05	0.00014	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—malignant glioma	2.72e-05	0.000136	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—malignant glioma	2.7e-05	0.000135	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.69e-05	0.000135	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.64e-05	0.000132	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—malignant glioma	2.63e-05	0.000132	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.63e-05	0.000132	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAV1—malignant glioma	2.62e-05	0.000131	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.56e-05	0.000128	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.5e-05	0.000126	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.48e-05	0.000124	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.46e-05	0.000123	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.39e-05	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.37e-05	0.000119	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.35e-05	0.000118	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.35e-05	0.000118	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—malignant glioma	2.33e-05	0.000117	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—malignant glioma	2.3e-05	0.000116	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—malignant glioma	2.29e-05	0.000115	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—malignant glioma	2.27e-05	0.000114	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—malignant glioma	2.18e-05	0.000109	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.16e-05	0.000108	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.14e-05	0.000107	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.14e-05	0.000107	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.13e-05	0.000107	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.12e-05	0.000106	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.1e-05	0.000105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—malignant glioma	2.03e-05	0.000102	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—malignant glioma	2.02e-05	0.000101	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—malignant glioma	1.98e-05	9.93e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—malignant glioma	1.87e-05	9.36e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.85e-05	9.29e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—malignant glioma	1.85e-05	9.27e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.83e-05	9.17e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.81e-05	9.09e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—malignant glioma	1.79e-05	8.99e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—malignant glioma	1.58e-05	7.93e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.51e-05	7.59e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.43e-05	7.18e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.4e-05	7e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.32e-05	6.6e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.3e-05	6.54e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—malignant glioma	1.17e-05	5.86e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—malignant glioma	1.14e-05	5.72e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.12e-05	5.59e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—malignant glioma	1.08e-05	5.39e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—malignant glioma	1.07e-05	5.34e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—malignant glioma	9.11e-06	4.57e-05	CbGpPWpGaD
